Codetta Bio introduced the Concerto platform at AACR in 2025 and initially made the technology available through a service-based Technology Access Program (TAP). Following strong customer engagement ...
REHOVOT, Israel, Nov. 12, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (EVGN), today announced the commercial expansion of Yalos® ...
Lavie Bio successfully completed testing of Yalos™ for winter wheat and will commence sales across the US for the 2024-2025 season Winter wheat is one of the crucial crops in North America and ...
Price of LYFGENIA reflects its value as a potentially curative gene therapy for sickle cell disease through durable production of anti-sickling adult hemoglobin (HbAT87Q) and resolution of ...
MENLO PARK, Calif.--(BUSINESS WIRE)-- Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced the appointment ...
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Nuvation Bio (NYSE:NUVB) received full U.S. FDA approval for ...
AviGa™ Bio HP70 is a bio-based, 70% cosmetic-grade glycolic acid available globally from April 14, 2026, with REACH registration ensuring uninterrupted European supply The launch marks a pivotal shift ...
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary ...
In addition to these key commercial appointments, Allison Frisbee has joined Orca Bio as a Senior Vice President, Legal, following roles at Kronos Bio, Jazz Pharmaceuticals and Bristol Myers Squibb, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results